The DIZG is investing in a new production facility for allogeneic devitalized tissue preparations to ensure safe patient care.
From the groundbreaking in 2021 to the topping-out ceremony and beyond – discover the progress here.
In the approximately 1,480 m² production area with its clean rooms, it will be possible to manufacture an additional 80,000-160.000 human tissue transplants from bone, tendons, acellular dermis, and fascia, in addition to the approximately 85,000 tissue transplants already produced annually. Production will start in 2026.
Since its foundation, around 868,000 transplants have been manufactured infection-free.
Since its foundation, around 933,000 transplants have been manufactured infection-free.